LogicMark, Inc. Announces Adoption of Shareholder Rights Agreement
LogicMark (LGMK) has implemented a Shareholder Rights Agreement with Nevada Agency and Transfer Company in response to Winvest Investment Fund's recent actions. This decision follows Winvest's claim of owning approximately 67% of LogicMark's common stock and its attempt to change company bylaws and board composition. LogicMark disputes Winvest's ownership claims and states their actions violate state and federal laws. The Rights Agreement includes a 'poison pill' provision triggered when any entity acquires 15% or more of outstanding shares, aiming to protect shareholder value while maintaining flexibility for Board-approved partnerships or acquisitions.
LogicMark (LGMK) ha implementato un Accordo sui Diritti degli Azionisti con la Nevada Agency and Transfer Company in risposta alle recenti azioni di Winvest Investment Fund. Questa decisione segue la richiesta di Winvest di detenere circa il 67% delle azioni ordinarie di LogicMark e il suo tentativo di modificare lo statuto della società e la composizione del consiglio. LogicMark contesta le pretese di proprietà di Winvest e afferma che le loro azioni violano leggi statali e federali. L'Accordo sui Diritti include una clausola 'poison pill' attivata quando un'entità acquisisce il 15% o più delle azioni in circolazione, con l'obiettivo di proteggere il valore per gli azionisti mantenendo al contempo la flessibilità per alleanze o acquisizioni approvate dal Consiglio.
LogicMark (LGMK) ha implementado un Acuerdo de Derechos de los Accionistas con Nevada Agency and Transfer Company en respuesta a las recientes acciones de Winvest Investment Fund. Esta decisión sigue la reclamación de Winvest de poseer aproximadamente el 67% de las acciones ordinarias de LogicMark y su intento de cambiar los estatutos de la empresa y la composición de la junta. LogicMark disputa las reclamaciones de propiedad de Winvest y afirma que sus acciones violan las leyes estatales y federales. El Acuerdo de Derechos incluye una disposición de 'poison pill' que se activa cuando cualquier entidad adquiere el 15% o más de las acciones en circulación, con el objetivo de proteger el valor para los accionistas mientras se mantiene la flexibilidad para asociaciones o adquisiciones aprobadas por la Junta.
로지크마크 (LGMK)는 최근 윈베스트 투자 펀드의 행동에 대응하여 네바다 에이전시 및 전환 회사와 주주 권리 협정을 체결했습니다. 이 결정은 윈베스트가 로지크마크의 보통주 약 67%를 소유한다고 주장하고 회사 정관 및 이사회 구성을 변경하려는 시도를 따릅니다. 로지크마크는 윈베스트의 소유 주장에 반대하며 그들의 행동이 주 및 연방법을 위반한다고 밝혔습니다. 권리 협정에는 어떤 주체가 발행 주식의 15% 이상을 인수할 때 발동되는 '포이즌 필' 조항이 포함되어 있으며, 이는 주주 가치를 보호하면서 이사회 승인 파트너십 또는 인수에 대한 유연성을 유지하는 것을 목표로 합니다.
LogicMark (LGMK) a mis en place un Accord sur les Droits des Actionnaires avec la Nevada Agency and Transfer Company en réponse aux récentes actions de Winvest Investment Fund. Cette décision fait suite à la revendication de Winvest d'être propriétaire d'environ 67% des actions ordinaires de LogicMark et à sa tentative de modifier les statuts de l'entreprise et la composition du conseil d'administration. LogicMark conteste les revendications de propriété de Winvest et déclare que leurs actions violent les lois fédérales et étatiques. L'Accord comprend une disposition de 'poison pill' qui se déclenche lorsqu'une entité acquiert 15% ou plus des actions en circulation, visant à protéger la valeur pour les actionnaires tout en maintenant la flexibilité pour des partenariats ou acquisitions approuvés par le Conseil.
LogicMark (LGMK) hat eine Aktionärsrechtevereinbarung mit der Nevada Agency and Transfer Company als Reaktion auf die jüngsten Aktionen des Winvest Investment Fund implementiert. Diese Entscheidung folgt auf die Behauptung von Winvest, etwa 67% der Stammaktien von LogicMark zu besitzen und den Versuch, die Unternehmenssatzung und die Zusammensetzung des Vorstands zu ändern. LogicMark widerspricht den Eigentumsansprüchen von Winvest und erklärt, dass deren Handlungen gegen staatliche und bundesstaatliche Gesetze verstoßen. Die Rechtevereinbarung enthält eine 'Poison-Pill'-Klausel, die aktiviert wird, wenn eine Einheit 15% oder mehr der ausgegebenen Aktien erwirbt, mit dem Ziel, den Wert für die Aktionäre zu schützen und gleichzeitig Flexibilität für vom Vorstand genehmigte Partnerschaften oder Übernahmen zu gewährleisten.
- Implementation of shareholder protection measures against hostile takeover attempts
- Maintains flexibility for future board-approved strategic partnerships and acquisitions
- Ongoing dispute with major claimed shareholder Winvest
- Potential corporate governance instability due to contested ownership claims
- Risk of legal disputes over ownership and control
Insights
The adoption of a shareholder rights agreement ("poison pill") is a significant defensive move by LogicMark against Winvest's attempted takeover. The 15% ownership threshold trigger is particularly aggressive, designed to prevent Winvest from acquiring additional shares without board approval. The legal dispute centers on Winvest's claim of 67% ownership and attempted bylaw changes, which LogicMark contests as materially inaccurate and illegal.
This rights agreement effectively creates a significant barrier to hostile takeovers by making any unauthorized acquisition above the threshold prohibitively expensive. However, it maintains flexibility for board-approved transactions, suggesting the company remains open to strategic alternatives that could benefit shareholders. The timing and structure of this defense mechanism indicates serious concerns about Winvest's actions and their potential impact on corporate governance.
This defensive measure represents a critical inflection point in LogicMark's corporate governance strategy. The board's swift implementation of the rights agreement signals serious concerns about Winvest's credibility and intentions. The dispute over share ownership percentages raises significant red flags about transparency and regulatory compliance.
The rights agreement's structure suggests a dual strategy:
- Immediate protection against hostile takeover attempts
- Preservation of strategic optionality for board-approved transactions
LOUISVILLE, Ky., Nov. 01, 2024 (GLOBE NEWSWIRE) -- LogicMark, Inc. (Nasdaq: LGMK), (“LogicMark” or the “Company”), a provider of personal safety, emergency response systems (PERS), health communications devices, and technology for the growing care and safety economy, today announced that it has entered into a Rights Agreement with Nevada Agency and Transfer Company (the “Rights Agreement”) to protect shareholder rights and long-term shareholder value.
This decision has been taken in response to recent actions by Winvest Investment Fund Management Corp. (“Winvest”), which recently disclosed in public filings with the U.S. Securities and Exchange Commission (“SEC”) that it (i) purportedly owns approximately
As reported in the Schedule 13D amendment filed by Winvest with the SEC on October 30, 2024, the Company delivered a cease and desist letter to Winvest on October 29, 2024, informing Winvest that the disclosure of its beneficial ownership in its public filings was materially inaccurate and that Winvest’s attempted actions described in the Winvest Consent violated state and federal law because it was not the holder of a majority of the Company’s voting stock. To date, Winvest’s only response via counsel has been that it does not agree with the Company’s assessment and that it would proceed accordingly.
Chia-Lin Simmons, President and Chief Executive Officer of LogicMark, commented, "Following a Board meeting held on October 30, 2024, LogicMark's Board, in consultation with its legal advisors, determined that under the circumstances, immediately implementing a Rights Agreement would best serve the long-term interests of the Company and its shareholders by preventing actions by Winvest, which the Board believes would undermine shareholder value.
The Rights Agreement aims to safeguard LogicMark's independence against Winvest’s recent actions and others who may attempt to assume control of the Company while maintaining the flexibility for potential future partnerships or acquisitions that align with long-term shareholder value."
The Board and management believe that the adoption of the Rights Agreement provides several benefits to LogicMark shareholders, including the following:
- Commitment to Long-Term Stability: The Board's adoption of the Rights Agreement shows a dedication to safeguarding shareholders' interests, focusing on the Company's stability and growth. It also indicates that the Board considers unsolicited takeover attempts as potentially risky to shareholder value.
- Openness to Future Partnerships: While the Rights Agreement discourages hostile takeovers, it does not limit the possibility of mergers or acquisitions that align with shareholder interests and have Board approval. This keeps the door open for future partnerships that could increase shareholder value.
- Hostile Takeover Protection: The Rights Agreement is structured to block any entity or individual from gaining control of LogicMark without Board approval. The possibility of a Right dividend —often referred to as a "poison pill"— that would occur once a person or entity acquires beneficial ownership of
15% or more of the Company's outstanding shares, aims to make such an acquisition prohibitively expensive or unattractive.
For more information regarding the Rights Agreement, the rights contemplated thereunder, and the Company’s newly-established Series G Non-Convertible Voting Preferred Stock, please refer to the Company’s Current Report on Form 8-K to be filed with the SEC on November 1, 2024, as well as any LogicMark's future filings with the SEC. The associated press release and SEC filings will also be accessible on the Company’s investor relations website.
About Us
LogicMark, Inc. (Nasdaq: LGMK) is on a mission to let people of all ages lead a life with dignity, independence, and the joy of possibility. The Company provides personal safety, personal emergency response systems (PERS), software apps, health communications devices, services, and technologies to create a Connected Care Platform. Made up of a team of leading technologists with a deep understanding of IoT, AI, and machine learning and a passionate focus on understanding consumer needs, LogicMark is dedicated to building a 'Care Village' with proprietary technology and creating innovative solutions for the care economy. The Company's PERS technologies are sold through the United States Veterans Health Administration, dealers, distributors, and direct-to-consumer. LogicMark has been awarded a contract by the U.S. General Services Administration that enables the Company to distribute its products to federal, state, and local governments. For more information visit LogicMark.com.
Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. Forward-looking statements include statements herein concerning the successful execution of the Company's business strategy, including without limitation, the Company’s intentions and beliefs regarding Winvest’s actions and the Company’s intended purposes for establishing entering into the Rights Agreement and establishing the Rights and their anticipated benefits to the Company and its shareholders. The Company's actual results could differ materially from those anticipated in these forward-looking statements due to various factors. Such risks and uncertainties include, among other things, the Company’s ability to successfully implement the Rights Agreement and defend shareholder value against Winvest’s actions, the Company’s ability to establish and maintain the proprietary nature of our technology through the patent process, as well as the Company’s ability to possibly license from others patents and patent applications necessary to develop products; the availability of financing; the Company's ability to implement its long-range business plan for various applications of its technology; the Company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company's technology; the Company's ability to maintain its Nasdaq listing for its Common Stock; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company's reports filed with the SEC.
Investor Relations Contact
investors@logicmark.com
FAQ
What is the purpose of LogicMark's (LGMK) new Rights Agreement?
What percentage ownership does Winvest claim in LogicMark (LGMK)?
What is the trigger point for LogicMark's (LGMK) poison pill provision?
When did LogicMark (LGMK) implement the Rights Agreement?
